Godsey & Gibb Inc’s CRISPR Therapeutics CRSP Stock Holding History

Godsey & Gibb Inc’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.66K	Buy
2024 Q2	–	Sell
2024 Q1	$3.07K	Buy
2023 Q1	–	Sell
2022 Q4	$8.13K	Buy
2022 Q3	–	Sell
2022 Q2	$12K	Buy